Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nanobiomedicine
Nanobiomedicine is not currently indexed in Scopus. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 1849-5435Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: About US$2,000 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Nanobiomedicine indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2014–2022).
What is the impact factor of Nanobiomedicine?
Nanobiomedicine has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.186, quartile Q4, with an H-index of 19.
How much does it cost to publish in Nanobiomedicine?
The publisher lists an article processing charge of about US$2,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Nanobiomedicine and what is its ISSN?
Nanobiomedicine is published by SAGE Publications Ltd. Its ISSN is 1849-5435.
Is Nanobiomedicine in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Nanobiomedicine open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Nanobiomedicine for 9 years, between 2014 and 2022. Coverage ended in 2022, 4 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 52 works and 2,157 citations for the title. Its most recent paper is from 2022, in line with the end of Scopus coverage in 2022, which suggests the journal stopped publishing around then.
How well cited is Nanobiomedicine? — open metrics via OpenAlex
Nanobiomedicine has an h-index of 24 and a 2-year mean of 0 citations per paper (OpenAlex).
Nanobiomedicine published 1 papers in 2022; its busiest recent year was 2016 with 16. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Are there integrity warnings for Nanobiomedicine? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2022. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2022
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from SAGE Publications Ltd
SAGE Publications Ltd has 624 other titles in our data; 552 are currently indexed in Scopus.
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.